Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06567886 · ClinicalTrials.gov registry record · NA

Fibromyalgia Sleep A to ZZZ Study

A NA study of Fibromyalgia, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
390
Enrollment target
1
Study location

NCT06567886: Recruiting NA study of Fibromyalgia, sponsored by University of Michigan.

NCT06567886 is a NA study of Fibromyalgia that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 390 participants, above the 174-participant average among 76 other Fibromyalgia trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06567886, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
390 participants
Enrollment target
1
Study location

Study Summary

This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.

Primary Outcome

The FIQR is 21 questions. Each question has 11 boxes similar to a visual analog scale. Questions include the difficulty associated with various physical activities and the severity of symptoms. The score for the questions is on a scale from 0 - 100, where lower scores represented better functional status.

Conditions Studied

Interventions

  • DEVICE Light Therapy
  • BEHAVIORAL Sleep Stabilization

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2024-09-27
Est. Completion 2029-03
Phase NA
University of Michigan

1,327 total trials

What NCT06567886 shows while recruiting

NCT06567886 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, above the 174-participant average among 76 other Fibromyalgia trials with a reported enrollment target (124% higher).

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Light Therapy is the first listed.

NCT06567886 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06567886 about?

NCT06567886 is a clinical study titled "Fibromyalgia Sleep A to ZZZ Study". This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.

What is the current status of trial NCT06567886?

This trial is currently recruiting. It is a NA study. The enrollment target is 390 participants. The study started on 2024-09-27. Estimated completion is 2029-03.

What conditions does trial NCT06567886 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT06567886?

The interventions under investigation include: Light Therapy (DEVICE), Sleep Stabilization (BEHAVIORAL).

Who is sponsoring clinical trial NCT06567886?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06567886 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06567886's enrollment target sits among peer trials

390 8th of 76 higher than 69 of 76 other Fibromyalgia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00397111 · 390 participants

    Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

  • NCT05335928 · 390 participants · Phase 3

    Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • NCT05445960 · 390 participants · NA

    Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery

  • NCT05997615 · 390 participants · Phase 1

    Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06567886, the US trial registry maintained by the National Library of Medicine. NCT06567886 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.